이 기사의 번역을 준비하고 있습니다. 그동안 영어 원문을 임시로 표시합니다.
비즈니스 · 1994. 6. 3.1 분 읽기
Review of General Biologics and Licensing Regulations
로컬 자동 번역 · 원본 출처 언어
요약
The Food and Drug Administration (FDA) is conducting a review of certain general biologics and licensing regulations and is requesting public comment on these regulations. This review is intended to identify regulations that are outdated, burdensome, inefficient, or otherwise unsuitable or unnecessary from a regulatory standpoint and in need of revision. This review is part of FDA's program to periodically review existing significant regulations. A request for comments on certain regulations for blood establishments and blood products will be published elsewhere in this issue of the Federal Register.
원본 출처 언어: Federal Register — Health and Human Services원문 발표 열기 →